Evidence map›Paper›PMID 36945109›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2023

Apelin is altered in subjects with autosomal dominant polycystic kidney disease and preserved kidney function.

Peter Janssens, Wilfried Cools, Nadia de Mota, Jean-Paul Decuypere, Vicente Torres, Karl Martin Wissing, Rudi Vennekens, Bert Bammens, Catherine Llorens-Cortes, Djalila Mekahli

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Peter JanssensDepartment of Nephrology and Arterial Hypertension, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel, Brussels, Belgium.
Wilfried CoolsVrije Universiteit Brussel, Interfaculty Center Data processing and Statistics, Brussels, Belgium.
Nadia de MotaCollège de France- INSERM U1050/CNRS UMR 7241, Center for Interdisciplinary Research in Biology, Paris, France.
Jean-Paul DecuyperePKD research group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Vicente TorresMayo Clinic College of Medicine, Division of Nephrology and Hypertension, Rochester, USA.
Karl Martin WissingDepartment of Nephrology and Arterial Hypertension, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel, Brussels, Belgium.
Rudi VennekensLaboratory of Ion Channel Research, Department of Cellular and Molecular Medicine, VIB Center for Brain and Disease Research, KU Leuven, Leuven, Belgium.
Bert BammensKU Leuven Department of Microbiology, Immunology and Transplantation, Nephrology and Renal Transplantation Research Group, Leuven, Belgium.
Catherine Llorens-CortesCollège de France- INSERM U1050/CNRS UMR 7241, Center for Interdisciplinary Research in Biology, Paris, France.
Djalila MekahliPKD research group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Polycystic Kidney, Autosomal DominantApelinHumansKidneyApelin

Identifiers

PMID36945109
PMCPMC10387394

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.